Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
2,1,3-Benzoxadiazole-4-sulfonyl chloride → Benzo[1,2,5]oxadiazole-4-sulfonic acid {4-[3-butyl-1-(2-fluoro-benzyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-ylmethyl]-phenyl}-amide
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|---|---|---|
| 반응물 | 2,1,3-Benzoxadiazole-4-sulfonyl chloride | HCID 2735446 | — |
| 반응물 | 1-(2-fluorobenzyl)-8-(4-aminobenzyl)-3-butyl-1H-purine-2,6(3H,7H)-dione | HCID 21891720 | — |
| 생성물 | Benzo[1,2,5]oxadiazole-4-sulfonic acid {4-[3-butyl-1-(2-fluoro-benzyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-ylmethyl]-phenyl}-amide | HCID 10326289 | — |
반응 단계
Prepared from 8-(4-amino-benzyl)-3-butyl-1-(2-fluoro-benzyl)-3,7-dihydro-purine-2,6-dione and benzo[1,2,5]oxadiazole-4-sulfonyl chloride. Purity (ELSD, based on MW=603.6)=95%.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 특허 번호 | US07148229B2 |
| 출처 데이터셋 | uspto-grants-2006_12 |
| ORD ID | ord-db1c90de923e4193a77312a394b1104c |
| 출처 메모 | uspto-grants-2006_12 |